SEC Form 4 · accession 0001493152-26-039816
Protagenic Therapeutics, Inc.\new · PTIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garo H Armen
Officer — EXEC. CHAIR & PRINCIPAL OFF · Director
Period of report
Aug 21, 2026
Accepted (ET)
Aug 24, 2026 · 1:20 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001022899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Aug 21, 2026 | P | 20,000 | $0.65 | A | 73,533 | D |
Table II — derivative securities
No Table II lines on this filing.